3 news items
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
CNTB
7 May 24
industry to develop innovative therapies to treat chronic inflammatory diseases with the goal of improving the lives of millions of those affected
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
CNTB
16 Apr 24
with the goal
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
CNTB
12 Feb 24
industry to develop innovative therapies to treat chronic inflammatory diseases with the goal of improving the lives of millions of those affected
- Prev
- 1
- Next